| Literature DB >> 35564626 |
Carlos Ojeda Sánchez1, Javier García-Pérez2,3, Diana Gómez-Barroso3,4, Alejandro Domínguez-Castillo2, Elena Pardo Romaguera5, Adela Cañete5, Juan A Ortega-García6,7, Rebeca Ramis2,3,7.
Abstract
BACKGROUND: Blue spaces have been a key part of human evolution, providing resources and helping economies develop. To date, no studies have been carried out to explore how they may be linked to paediatric oncological diseases.Entities:
Keywords: childhood cancer; childhood leukaemia; environmental factors; incidence; spatial epidemiology; urban blue spaces
Mesh:
Year: 2022 PMID: 35564626 PMCID: PMC9103937 DOI: 10.3390/ijerph19095232
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Spanish regions selected for the study.
Childhood leukaemia cases, sensitivity groups, and controls’ characteristics.
| Characteristics | Controls | Cases | Same Address (n = 515) | Cases < 3 Years | ||
|---|---|---|---|---|---|---|
| Sex, n (%) | ||||||
| Boy | 3126 (55.7%) | 521 (55.7%) | 283 (55%) | 224 (54.6%) | ||
| Girl | 2490 (44.3%) | 415 (44.3%) | 232 (45%) | 0.794 # | 186 (45.4%) | 0.122 # |
| Age at diagnosis, mean (SD) | x | 4.9 (0.12) | 5.0 (3.6) | 0.625 * | 2.0 (1) | x |
| Activity Rate, mean (SD) | 76.3 (4.8) | 76 (0.15) | 75.8 (4.7) | 0.535 * | 75.9 (4.5) | 0.790 * |
| SES, mean (SD) | 1.06 (0.13) | 1.05 (0.12) | 1.05 (0.12) | 0.605 * | 1.04 (0.12) | 0.7264 * |
| Histologic subtype, n (%) | ||||||
| ALL | x | 758 (81.0%) | 421 (81.8%) | 305 (74.4%) | ||
| AML | x | 144 (15.4%) | 78 (15.1%) | 84 (20.5%) | ||
| CML | x | 7 (0.7%) | 4 (0.8%) | 2 (0.5%) | ||
| Other specific leukaemia | x | 17 (1.8%) | 7 (1.4%) | 13 (3.2%) | ||
| Non-specific leukaemia | x | 10 (1.1%) | 5 (0.9%) | 0.974 # | 6 (1.4%) | 0.062 # |
| BSs within 250 m buffer, n (%) | ||||||
| Yes | 708 (12.6%) | 102 (10.9%) | 55 (10.7%) | 46 (11.2%) | ||
| No | 4908 (87.4%) | 834 (89.1%) | 460 (89.3%) | 0.898 # | 364 (87.8%) | 0.032 # |
| BSs within 500 m buffer, n (%) | ||||||
| Yes | 1630 (29%) | 240 (25.6%) | 135 (26.2%) | 99 (24.2%) | ||
| No | 3986 (71%) | 696 (74.4%) | 380 (73.8%) | 0.812 # | 311 (75.8%) | 0.340 # |
| BSs within 750 m buffer, n (%) | ||||||
| Yes | 2353 (41.9%) | 354 (37.8%) | 205 (39.8%) | 151 (36.8%) | ||
| No | 3363 (58.1%) | 582 (62.2%) | 310 (60.2%) | 0.457 # | 259 (63.2%) | 0.119 # |
| BSs within 1000 m buffer, n (%) | ||||||
| Yes | 2934 (52.2%) | 455 (48.6%) | 264 (51.3%) | 196 (52.2%) | ||
| No | 2682 (47.8%) | 481 (51.4%) | 251 (48.7%) | 0.334 # | 214 (47.8%) | 0.074 # |
| DGUR, n (%) | ||||||
| Densely populated area | 5042 (89.8%) | 867 (92.6%) | 476 (92.4%) | 378 (92.2%) | ||
| Non-densely populated areas | 574 (10.2%) | 69 (7.4%) | 39 (7.6%) | 0.889 # | 32 (7.8%) | 0.781 # |
| PM10 levels at residence, mean (SD) | 26.02 (0.07) | 26.2 (5.41) | 25.9 (5.32) | 0.314 * | 25.0 (5.29) | <0.01 * |
| Surrounding greenness (NDVI), median (IQR) | ||||||
| in 250 m buffer | −0.06 (0.10) | −0.07 (0.11) | −0.06 (0.11) | 0.904 ¥ | −0.05 (0.15) | 0.012 ¥ |
| in 500 m buffer | −0.04 (0.11) | −0.05 (0.13) | −0.05 (0.13) | 0.948 ¥ | −0.03 (0.16) | 0.014 ¥ |
| in 750 m buffer | −0.03 (0.12) | −0.03 (0.14) | −0.03 (0.14) | 0.898 ¥ | −0.02 (0.16) | 0.013 ¥ |
| in 1000 m buffer | −0.02 (0.13) | −0.03 (0.14) | −0.03 (0.15) | 0.851 ¥ | −0.01 (0.17) | 0.016 ¥ |
a—p value from main group of cases compared to sensitivity group. # Chi-square test for categorical variables, ¥ Kruskal–Wallis test, * Student’s t-test. Abbreviations: SD—standard deviation, IQR—interquartile range, ALL—acute lymphoblastic leukaemia, AML—acute myeloblastic leukaemia, CML—chronic myeloblastic leukaemia, BSs—blue spaces, DGUR—degree of urbanisation, NDVI—Normalized Difference Vegetation Index.
Blue-space analysis for overall childhood leukaemia, ALL and AML subtypes, and identified cases with same address at birth and diagnosis results. Adjusted models for sex, birth year, SES, activity rate, DGUR, PM10 levels, and surrounding greenness.
| Analysis Group | Exposure Category | Controls (n) | Cases (n) | Adjusted | |
|---|---|---|---|---|---|
| Childhood Leukaemia | |||||
| Reference | 2682 | 481 | - | ||
| 250 m | 708 | 102 | 0.77 (0.60–0.97) | 0.031 | |
| 500 m | 1630 | 240 | 0.78 (0.65–0.93) | 0.006 | |
| 750 m | 2353 | 354 | 0.80 (0.68–0.93) | 0.005 | |
| 1000 m | 2934 | 455 | 0.84 (0.72–0.97) | 0.019 | |
| ALL subtype | |||||
| Reference | 2682 | 388 | - | ||
| 250 m | 708 | 73 | 0.68 (0.51–0.89) | 0.006 | |
| 500 m | 1630 | 188 | 0.75 (0.62–0.91) | 0.004 | |
| 750 m | 2353 | 283 | 0.79 (0.67–0.94) | 0.008 | |
| 1000 m | 2934 | 370 | 0.85 (0.72–1.00) | 0.049 | |
| AML subtype | |||||
| Reference | 2682 | 78 | - | ||
| 250 m | 708 | 23 | 1.06 (0.63–1.71) | 0.818 | |
| 500 m | 1630 | 39 | 0.77 (0.50–1.15) | 0.210 | |
| 750 m | 2353 | 55 | 0.72 (0.50–1.04) | 0.084 | |
| 1000 m | 2934 | 66 | 0.70 (0.49–0.99) | 0.045 | |
| Same address | |||||
| Reference | 2682 | 251 | - | ||
| 250 m | 708 | 55 | 0.77 (0.56–1.04) | 0.100 | |
| 500 m | 1630 | 135 | 0.82 (0.65–1.03) | 0.097 | |
| 750 m | 2353 | 205 | 0.87 (0.71–1.07) | 0.198 | |
| 1000 m | 2934 | 264 | 0.92 (0.76–1.12) | 0.407 | |
| Cases < 3 years | |||||
| Reference | 2682 | 214 | - | ||
| 250 m | 708 | 46 | 0.79 (0.55–1.10) | 0.172 | |
| 500 m | 1630 | 99 | 0.73 (0.56–0.94) | 0.017 | |
| 750 m | 2353 | 151 | 0.77 (0.61–0.97) | 0.025 | |
| 1000 m | 2934 | 196 | 0.81 (0.66–1.01) | 0.056 |
a—OR and 95% CI for each distance buffer taking as reference subjects without blue space in each buffer. Abbreviations: BS—blue space, OR—odds ratio, CI—confidence interval, ALL—acute lymphoblastic leukaemia, AML—acute myeloblastic leukaemia, SES—socioeconomic status, DGUR—degree of urbanisation.
Figure 2Adjusted models’ graphical representations. Blue points represent ORs, blue-space exposure for each buffer distance compared to the reference group (subjects who did not have any blue space in their 1 km exposure buffers). Lower and upper 95%CIs are represented by orange points. (a) Overall childhood leukaemia, (b) ALL subtype, (c) AML subtype, (d) Cases with same address at birth and diagnosis, (e) cases <3 years old.